Skip to main content

Medications for Multiple Sclerosis - Page 2

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
ocrelizumab 5.0 182 reviews for ocrelizumab to treat Multiple Sclerosis Rx N
Generic name:
ocrelizumab systemic
Brand name:
Ocrevus
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Ocrevus 5.0 166 reviews for Ocrevus to treat Multiple Sclerosis Rx N
Generic name:
ocrelizumab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
peginterferon beta-1a 5.3 15 reviews for peginterferon beta-1a to treat Multiple Sclerosis Rx C N X
Generic name:
peginterferon beta-1a systemic
Brand name:
Plegridy
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Aubagio 5.4 86 reviews for Aubagio to treat Multiple Sclerosis Rx X N X
Generic name:
teriflunomide systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Plegridy 5.4 14 reviews for Plegridy to treat Multiple Sclerosis Rx C N X
Generic name:
peginterferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
teriflunomide 5.5 88 reviews for teriflunomide to treat Multiple Sclerosis Rx X N X
Generic name:
teriflunomide systemic
Brand name:
Aubagio
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cyclophosphamide Off-label 6.0 3 reviews for cyclophosphamide to treat Multiple Sclerosis Rx D N
Generic name:
cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
methylprednisolone 6.0 3 reviews for methylprednisolone to treat Multiple Sclerosis Rx C N
Generic name:
methylprednisolone systemic
Brand names:
Solu-Medrol, Medrol
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Lemtrada 6.3 20 reviews for Lemtrada to treat Multiple Sclerosis Rx C N
Generic name:
alemtuzumab systemic
Drug class:
CD52 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tecfidera 6.3 98 reviews for Tecfidera to treat Multiple Sclerosis Rx C N
Generic name:
dimethyl fumarate systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
alemtuzumab 6.5 21 reviews for alemtuzumab to treat Multiple Sclerosis Rx C N
Generic name:
alemtuzumab systemic
Brand name:
Lemtrada
Drug class:
CD52 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
dimethyl fumarate 6.5 109 reviews for dimethyl fumarate to treat Multiple Sclerosis Rx C N
Generic name:
dimethyl fumarate systemic
Brand name:
Tecfidera
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Kesimpta 6.8 64 reviews for Kesimpta to treat Multiple Sclerosis Rx C N
Generic name:
ofatumumab systemic
Drug class:
CD20 monoclonal antibodies, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ofatumumab 6.8 64 reviews for ofatumumab to treat Multiple Sclerosis Rx C N
Generic name:
ofatumumab systemic
Brand name:
Kesimpta
Drug class:
CD20 monoclonal antibodies, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Betaseron 6.9 8 reviews for Betaseron to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1b systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
interferon beta-1b 6.9 8 reviews for interferon beta-1b to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1b systemic
Brand names:
Betaseron, Extavia
Drug class:
interferons
For consumers:
dosage, interactions, side effects
Rebif 6.9 29 reviews for Rebif to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
fingolimod 7.1 99 reviews for fingolimod to treat Multiple Sclerosis Rx C N
Generic name:
fingolimod systemic
Brand names:
Gilenya, Tascenso ODT
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Gilenya 7.1 96 reviews for Gilenya to treat Multiple Sclerosis Rx C N
Generic name:
fingolimod systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Avonex 7.2 45 reviews for Avonex to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
glatiramer 7.3 152 reviews for glatiramer to treat Multiple Sclerosis Rx B N
Generic name:
glatiramer systemic
Brand names:
Copaxone, Glatopa
Drug class:
other immunostimulants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Mayzent 7.3 8 reviews for Mayzent to treat Multiple Sclerosis Rx N
Generic name:
siponimod systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
siponimod 7.3 9 reviews for siponimod to treat Multiple Sclerosis Rx N
Generic name:
siponimod systemic
Brand name:
Mayzent
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
interferon beta-1a 7.5 96 reviews for interferon beta-1a to treat Multiple Sclerosis Rx C N X
Generic name:
interferon beta-1a systemic
Brand names:
Rebif, Avonex, Avonex Prefilled Syringe, Avonex Pen, Rebif Rebidose
Drug class:
interferons
For consumers:
dosage, interactions, side effects
Copaxone 7.6 133 reviews for Copaxone to treat Multiple Sclerosis Rx B N
Generic name:
glatiramer systemic
Drug class:
other immunostimulants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Topics under Multiple Sclerosis

Learn more about Multiple Sclerosis

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.